Asset Allocation

As of June 30, 2026.
Type % Net
Cash 16.34%
Stock 10.50%
Bond 72.77%
Convertible 0.00%
Preferred 0.00%
Other 0.38%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 89.28%    % Emerging Markets: 2.22%    % Unidentified Markets: 8.50%

Americas 83.28%
83.26%
Canada 2.56%
United States 80.70%
0.02%
As of June 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.21%
United Kingdom -0.36%
0.57%
Belgium 0.00%
Finland 0.00%
France 0.08%
Germany 0.06%
Ireland 0.24%
Italy 0.00%
Netherlands 0.08%
Norway 0.02%
Spain 0.00%
Sweden 0.05%
Switzerland 0.03%
0.00%
0.00%
Greater Asia 8.00%
Japan 3.57%
0.23%
Australia 0.19%
2.01%
Singapore 0.22%
South Korea 1.78%
2.20%
Philippines 2.20%
Unidentified Region 8.50%

Bond Credit Quality Exposure

AAA 6.67%
AA 80.64%
A 5.22%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 7.47%
Short Term 0.00%
As of June 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
8.12%
Materials
0.73%
Consumer Discretionary
4.16%
Financials
2.80%
Real Estate
0.44%
Sensitive
25.92%
Communication Services
4.04%
Energy
0.63%
Industrials
3.01%
Information Technology
18.24%
Defensive
5.06%
Consumer Staples
2.05%
Health Care
2.38%
Utilities
0.63%
Not Classified
0.16%
Non Classified Equity
0.16%
As of June 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2026
Type % Net
Government 75.36%
Corporate 19.42%
Securitized 0.00%
Municipal 3.07%
Other 2.15%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
59.77%
Less than 1 Year
59.77%
Intermediate
40.21%
1 to 3 Years
40.21%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.02%
As of June 30, 2026
View Bond Maturity Exposure
Start Trial